Jingjing Wang

Title: Innovations of Jingjing Wang in Pharmaceutical Composition

Introduction

Jingjing Wang is a notable inventor based in Xuzhou, China. She has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. Her innovative work focuses on addressing morphine-induced analgesic tolerance, a critical issue in pain treatment.

Latest Patents

Jingjing Wang holds a patent for a pharmaceutical composition and method aimed at relieving or eliminating morphine-induced analgesic tolerance. The patent describes a composition that includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, or injecting the short peptide followed by morphine administration.

Career Highlights

Jingjing Wang is affiliated with Xuzhou Medical University, where she continues her research and development in pharmaceutical sciences. Her work has garnered attention for its potential to improve pain management strategies and enhance patient outcomes.

Collaborations

Jingjing collaborates with esteemed colleagues, including Qiongyao Tang and Zhe Zhang, who contribute to her research endeavors. Their combined expertise fosters a productive environment for innovation in the pharmaceutical field.

Conclusion

Jingjing Wang's contributions to pharmaceutical compositions demonstrate her commitment to advancing pain management solutions. Her innovative approaches have the potential to significantly impact the treatment of patients experiencing morphine-induced analgesic tolerance.